Zanamivir: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk mNo edit summary |
imported>David E. Volk m (→External links) |
||
| Line 15: | Line 15: | ||
== External links == | == External links == | ||
* {{DailyMed}} | * {{DailyMed}} | ||
* | * {{MedMaster}} | ||
* {{DrugBank}} | |||
Revision as of 12:43, 5 March 2008
Zanamivir is a guanido-neuraminic acid that is a neuraminidase inhibitor used as an antiviral drug to treat influenza A and B.
Its IUPAC chemical name is (4S,5R,6R)-5-acetamido-4-(diaminomethylideneamino)-6-[(1R,2R)-1,2,3-trihydroxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid and its chemical formula is C12H20N4O7.
Brand names
- GANA
- GNA
- Relenza (GlaxoSmithKline)
- ZMR
- Zanamavir
External links
- Zanamivir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank